posted on October 05, 2009 16:13
Coldstream Laboratories Inc. (CLI), providing full service GMP small-batch sterile drug product production, has successfully completed its second year in business. Based at Coldstream Research Campus, CLI has manufactured more than a dozen different drug products for pre-clinical through Phase III clinical trials since the $17 million, 20,000 sq. ft. facility has been in operation.
The University of Kentucky created Coldstream Laboratories in 2007 from the College of Pharmacy’s Center for Pharmaceutical Sciences and Technology. “We could not be more pleased that Coldstream Laboratories has achieved important milestones in its first two years of operations,” says UK President Lee T. Todd Jr.
According to Len Heller, UK vice president for Commercialization & Economic Development, who also serves as chair of the CLI board of directors, “Coldstream Laboratories is on track with our business plan objectives, meeting projected revenue and moving toward profitability.”